Advanced BioMedical Technologies, Inc. Other Income and Expense
Advanced BioMedical Technologies, Inc. reported Other Income and Expense of -$86.94 thousand for the 3-month period ending 2021-07-31, per its 10-Q filed 2021-09-13.
Discontinued › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2021-09-13
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for the quarter ending 2021-07-31 was -$86.94K.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for the quarter ending 2021-04-30 was -$75.94K.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for the quarter ending 2021-01-31 was -$83.40K, a 332.60% decline year-over-year.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for the quarter ending 2020-10-31 was -$83.13K.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for fiscal 2020 was -$225.38K.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for fiscal 2019 was -$344.08K.
- Advanced BioMedical Technologies, Inc. nonoperating income (expense) for fiscal 2018 was -$319.30K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2021-07-31 | -$86.94K 10-Q · filed 2021-09-13 | -$162.88K derived: sum of 2 quarters · filed 2021-09-13 | -$246.28K 10-Q · filed 2021-09-13 | -$329.41K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-04-30 | -$75.94K 10-Q · filed 2021-06-21 | -$159.34K 10-Q · filed 2021-06-21 | -$242.47K derived: sum of 3 quarters · filed 2021-06-21 | -$331.25K derived: sum of 4 quarters · filed 2021-09-13 |
| 2021-01-31 | -$83.40K 10-Q · filed 2021-03-22 | -$166.53K derived: sum of 2 quarters · filed 2021-03-22 | -$255.32K derived: sum of 3 quarters · filed 2021-09-13 | -$344.63K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-10-31 | -$83.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | -$171.91K derived: sum of 2 quarters · filed 2021-09-13 | -$261.23K derived: sum of 3 quarters · filed 2021-09-13 | -$225.38K 10-K · filed 2021-01-29 |
| 2020-07-31 | -$88.78K 10-Q · filed 2021-09-13 | -$178.10K derived: sum of 2 quarters · filed 2021-09-13 | -$142.25K 10-Q · filed 2021-09-13 | -$229.12K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | -$89.32K 10-Q · filed 2021-06-21 | -$53.46K 10-Q · filed 2021-06-21 | -$140.33K derived: sum of 3 quarters · filed 2021-06-21 | -$227.78K derived: sum of 4 quarters · filed 2021-06-21 |
| 2020-01-31 | $35.86K 10-Q · filed 2021-03-22 | -$51.01K derived: sum of 2 quarters · filed 2021-03-22 | -$138.46K derived: sum of 3 quarters · filed 2021-03-22 | -$225.61K derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-10-31 | -$86.87K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-29 | -$174.32K derived: sum of 2 quarters · filed 2021-01-29 | -$261.47K derived: sum of 3 quarters · filed 2021-01-29 | -$344.08K 10-K · filed 2021-01-29 |
| 2019-07-31 | -$87.45K 10-Q · filed 2020-09-21 | -$174.60K derived: sum of 2 quarters · filed 2020-09-21 | -$257.21K 10-Q · filed 2020-09-21 | -$333.75K derived: sum of 4 quarters · filed 2020-09-21 |
| 2019-04-30 | -$87.15K 10-Q · filed 2020-06-22 | -$169.76K 10-Q · filed 2020-06-22 | -$246.30K derived: sum of 3 quarters · filed 2020-08-20 | -$325.92K derived: sum of 4 quarters · filed 2020-08-20 |
| 2019-01-31 | -$82.61K 10-Q/A · filed 2020-08-20 | -$159.15K derived: sum of 2 quarters · filed 2020-08-20 | -$238.77K derived: sum of 3 quarters · filed 2020-08-20 | |
| 2018-10-31 | -$76.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$156.15K derived: sum of 2 quarters · filed 2020-03-20 | -$319.30K 10-K · filed 2020-03-20 | |
| 2018-07-31 | -$79.62K 10-Q · filed 2019-09-20 | -$242.77K 10-Q · filed 2019-09-20 |